Navigation Links
Large Scale Multiple Sclerosis Vaccine Trial to Be Initiated By PharmaFrontiers

It might not be long before a vaccine for multiple sclerosis is made available. Following the promising results of a multiple sclerosis vaccine trial// in a small group of patients, PharmaFrontiers, a leading pharmaceutical company is all set to test it’s vaccine on a large scale.

Multiple sclerosis is a disease in which the myelin sheath, surrounding the nerve fibers in the spinal cord and brain is destroyed. Owing to destruction of this protective sheath, the transmission of nerve impulses to the brain is affected. Approximately 2.5 million people are afflicted by the disease, every year.

The vaccine contains inactivated myelin-specific T cells, normally found in the immune system. These cells are produced in the laboratory by radiation treatment of the extracted, multiplied and processed T-lymphocytes. The cells are then re-injected back into the patient, activating the immune system. It has been known from previous trials that re-injection of the modified T-cells eliminates the damaged nerve cells.

In some cases, the immune system also attacks the normal cells, leading to complications. In view of the above drawback, the researchers have been urged to be cautious by MS experts, who point out to other vaccine trials that have been ineffective.

The new vaccine trial would compare the progress of the disease among 100 people who have already received the vaccination with the control group (not vaccinated). It is believed that if the results of the earlier study were replicated, it might even be possible to attenuate or stop the disease progress.


'"/>




Page: 1

Related medicine news :

1. The Link Between Larger Birth Weight And Cancer Risk
2. Worlds Largest Cord Blood Bank to be started in India
3. India Has The Oldest And Largest Collection Of Preserved Mosquitoes – Mosquito Museu
4. Fear Of Dengue Epidemic Looms Large: Fever Kills Five in Pakistan
5. Visualization Found To Be Largely Dependent On The Brain
6. Large Scale Study On H5N1 Conducted
7. Pre-eclampsia Pronounced With Intake of Vitamins in Large Doses
8. Large Ambulances To Handle Obese patients In Vegas
9. Heart Related Problems-The Largest Killers In Andhra Pradesh
10. Large scale culling of poultry effected at Cote dIvoire following bird flu outbreak.
11. Children’s Center to Lead Largest-Ever Study on Kidney Disease in Childre
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... June 23, 2017 , ... Ulster University, Magee Campus ... from 9 am to 3 pm to present to graduate students exciting new and ... an original curriculum project led by The Health Improvement Service of the Western Health ...
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, ... families and business owners in North Central West Virginia, is embarking on a ... differently abled residents in the region. , The Stepping Stones organization offers a ...
(Date:6/22/2017)... Indianapolis, IN (PRWEB) , ... June 22, 2017 ... ... employee benefits advisory organization, is pleased to welcome Whipple & Company as its ... on the clear purpose of balancing their clients’ risk while tailoring optimized benefit ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... awards for environmental excellence. Maryland Recycling Network has awarded the Baltimore VA Medical ... Outstanding Small Government Program Award for its efforts to promote waste reduction and ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... that Claritas Capital, a Nashville-based private equity firm, has invested $3.35 million in ... for some time, and Claritas Capital offers the smart money, speed to market ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 8, 2017  Less than a month ago, amateur ... 200,000 companies, including hospital networks, in over 150 countries. ... of the largest online extortion attempts ever recorded. With ... it is imperative that providers understand where the risks ... this — and many other very real cyber threats.  ...
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: